Pear Therapeutics

Pear Prescription Digital Therapeutics (PDT) Digest

Pear Prescription Digital Therapeutics (PDT) Digest

Pear Therapeutics Launches Pear Prescription Digital Therapeutics Digest, Provides Roadmap for Payer Coverage Considerations

  • Pear Therapeutics is the leader in developing and commercializing prescription digital therapeutics (PDTs) to treat serious disease, with three FDA-authorized PDTs
  • Inaugural edition of the Digest explores employer and payer stakeholder knowledge of PDTs as well as current considerations and perceptions that compromise the coverage landscape

Download PDT Digest